| Ms Lorna Louise Netupsky-lang, OTR/L | |
|
Attn: Credentials Office, Cmr 442, Apo, AE 09042 | |
| (496) 221-172274 | |
| (496) 221-172941 |
| Full Name | Ms Lorna Louise Netupsky-lang |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | Attn: Credentials Office, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982661765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 731 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lorna Louise Netupsky-lang, OTR/L Cmr 445, Box 59, Apo, AE 09046 Ph: (497) 031-152697 | Ms Lorna Louise Netupsky-lang, OTR/L Attn: Credentials Office, Cmr 442, Apo, AE 09042 Ph: (496) 221-172274 |
News Archive
WHAT: A new study in human cells has singled out a molecule that specifically directs immune cells to develop the capability to produce an allergic response. The signaling molecule, called thymic stromal lymphopoietin (TSLP), is key to the development of allergic diseases such as asthma, atopic dermatitis (eczema) and food allergy.
States spend up to $15 billion a year in medical expenses related to obesity, according to a new study by researchers at RTI International, Duke University, and the federal Agency for Healthcare Research and Quality.
Tübingen researchers have shown that image processing in the eye is more extensive than previously thought. They investigated the channels that transmit information from the eye to the brain.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
› Verified 3 days ago
Sharon M. Newton, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Cmr 442, Attn Credentials Office, Apo, AE 09042 Phone: 496-221-172274 | |
Arlene C Labeste, M.S. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Phone: 351-966-492155 | |
Stanley T Breuer, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-7163 | |
Miss Jessica Levy, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center Cmr 402, Apo, AE 09180 Phone: 717-575-5966 | |
Karena Lehman, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 5115, Apo, AE 09461 Phone: 314-226-8561 | |
Jacqueline May Tamayo, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-4077 | |
Sandra Moore, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Psc 76 Box 263, 65th Med Group/sgh, Apo, AE 09720 Phone: 505-299-2643 |